Announced Fri, 26 Jun · 18:17 IST
MedPlus subsidiary gets drug license suspension orders at 3 stores
Business Updates View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.7%1-day move
₹839.00
prior close
₹842.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1-1.2-1.6-1.1-3.7-2.6-2.3-1.9-2.6-3.0-4.5———
Up moveDown movePending
AI summary
MedPlus Health Services subsidiary Optival Health Solutions received three drug license suspension orders for stores in Karnataka and Andhra Pradesh. The Hubli store faces a one-day suspension (around Rs 0.22 lakh revenue loss), Gadag store two days (Rs 0.60 lakh), and Attapur store three days (Rs 0.76 lakh). Total potential revenue impact is just Rs 1.58 lakh. Orders were issued by the Drugs Control Administration under Rule 65 of the Drugs and Cosmetics Act, 1940.
Likely market impact
Financial impact is negligible at Rs 1.58 lakh across three stores. Routine compliance matter, unlikely to affect overall operations or stock price.